Obesity core curriculum

TY - JOUR

T1 - Obesity core curriculum

AU - ASGE Training Committee

AU - Pannala, Rahul

AU - Sharaiha, Reem Z.

AU - Sullivan, Shelby A.

AU - Wagh, Mihir S.

AU - Cohen, Jonathan

AU - Thompson, Christopher C.

N1 - Funding Information: Dr Pannala is a consultant for HCL Technologies, the recipient of research support and general payments from Apollo Endosurgery, and the recipient of general payments from Boston Scientific, Abbvie, and Olympus. Dr Sharaiha is a consultant for and the recipient of research support from Aspire Bariatrics, the recipient of research support from Lumendi LLC, and the recipient of general payments from Apollo Endosurgery, Boston Scientific, Conmed, Cook Medical, US Endoscopy, Shire North America, Microtech Endoscopy, Endogastric solutions, Covidien LP, Ninepoint Medical, Takeda Pharmaceuticals, Allergan Inc, Siemens Medical Solutions, Medigus Ltd, Valeant Pharmaceuticals, Mauna Kea Technologies, and Ironwood Pharmaceuticals. Dr Sullivan is a consultant for Aspire Bariatrics, USGI Medical, Obalon Therapeutics, GI Dynamics, Elira, Spatz FGIA, Endo Tools Therapeutics, Phenomix Sciences, and Nitinotes; the recipient of research support from Aspire Bariatrics, Allurion, BARONova, Elira, Finch Therapeutics, Obalon Therapeutics, and ReBiotix; and the holder of stock warrants from Elira. Dr Wagh is a consultant for Medtronic; the recipient of general payments from Boston Scientific, Lumendi LLC, Conmed Corporation, Endogastric Solutions, Pinnacle Biologis, US Endoscopy, Olympus America, ERBE USA, Ninepoint Medical, Cook Medical, Pentax of America, Torax Medical, Apollo Endosurgery; and the recipient of general payments and research support from Merit Medical. Dr Cohen is a consultant and speaker for Olympus, Otsuka, and Ferring; an advisor for Virtual Health Partners and Stratis (pending); the recipient of royalties from Wiley and Up-to-Date; and the recipient of general payments from AMAG Pharmaceuticals, QOL Medical LLC, Janssen Biotech Inc, Synergy Pharma, US Endoscopy, Olympus Latin America, Boston Scientific, Covidien LP, Valeant Pharmaceuticals, Shire NA, Takeda Pharmaceuticals, Merck, Sharp and Dohme Corporation. Dr Thompson is the recipient of research support from Aspire Bariatrics, Boston Scientific, and the recipient of general payments from Olympus Corporation, Boston Scientific, Spiration Inc, Covidien LP, Apollo Endosurgery, Aspire Bariatrics, Fujifilm New Development, ERBE USA, Microtech Endoscopy, Endogastric Solutions, and Olympus Latin America.

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85084591076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084591076&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2019.07.007

DO - 10.1016/j.gie.2019.07.007

M3 - Article

C2 - 31302093

AN - SCOPUS:85084591076

SN - 0016-5107

VL - 91

SP - 1221

EP - 1229

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

IS - 6

ER -